BCL-2 inhibitor ABT-737 effectively targets leukemia-initiating cells with differential regulation of relevant genes leading to extended survival in a NRAS/BCL-2 mouse model of hig... by Gorombei, P, Guidez, F, Ganesan, S, Chiquet, M, Pellagatti, A, Goursaud, L, Tekin, N, Beurlet, S, Patel, S, Guerenne, L, Le Pogam, C, Setterblad, N, de la Grange, P, LeBoeuf, C, Janin, A, Noguera, M-E, Sarda-Mantel, L, Merlet, P, Boultwood, J, Konopleva, M, Andreeff, M, West, R, Pla, M, Adès, L, Fenaux, P, Krief, P, Chomienne, C, Omidvar, N, Padua, RA